Dentistry News
-
CD Formulation Announces Ability to Develop Liquid Dosage Forms
CD Formulation is known as a CRO service provider for custom pharmaceutical formulation projects. In a recent statement, the company announced its ability in liquid dosage forms development for customers worldwide who are looking for liquid dosage forms solutions for their drug development projects. There are different types of dosage forms, such as solid dosage form, liquid dosage form, ...
-
Rubius Therapeutics to Present Trials in Progress Poster on the Phase 1 Clinical Trial of RTX-321 for HPV 16-Positive Cancers at the 2021 American Society of Clinical Oncology Annual Meeting
Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an entirely new class of cellular medicines called Red Cell Therapeutics™, today announced that the Company will present a Trials in Progress poster presentation for its lead artificial antigen-presenting (aAPC) cell program, RTX-321, at the American ...
-
Notitia Biotechnologies company announces expansion of study population for Covid-19 phase 2 study (COVGUT20) for NBT-NM108
After months of preparation, Notitia Biotechnologies Company (Notitia) announced that its COVID-19 Phase 2 study (COVGUT20) for NBT-NM108 has been given support by the Food and Drug Administration (FDA) to expand its study population to all symptomatic COVID-19 patients. "Previously, our trial focused on COVID-19 patients with type 2 diabetes and prediabetes. Now with this timely expansion to ...
-
Statistics show: the risk of catching the coronavirus from surfaces is low
When the coronavirus began spreading around the world, people started to disinfect surfaces and wash their hands more often. During the early days of the pandemic, headlines told us the virus could survive even for days on surfaces and therefore surfaces could be potential sources of infection. Also, health institutions were recommending people to disinfect surfaces to prevent virus transmission. ...
-
Align technology’s invisalign brand is the official smile partner of U.S. SKI & Snowboard
Align Technology, Inc. (Nasdaq: ALGN), makers of the Invisalign® clear aligner system, today announced a partnership with U.S. Ski & Snowboard, making the Invisalign brand the Official Smile of U.S. Ski & Snowboard, the Olympic national governing body of ski and snowboard sports in the United States. The multi-year, worldwide sponsorship includes development of original Invisalign ...
-
Lakhmir Chawla, MD, of Silver Creek Pharmaceuticals Joins ExThera Medical Board of Directors
Professor Lakhmir Chawla, MD, has joined the board of directors of ExThera Medical Corporation, a privately held medical technology company whose Seraph 100 Microbind Affinity Blood Filter is authorized in the United States to treat critically ill COVID-19 patients. Dr. Chawla also serves as the Chair of the Scientific Advisory Board at the company Dr. Chawla is an internationally renowned ...
-
Arbitrator Requires SDC Financial, Llc to Pay Align an Additional $45.5 Million for A Total Award of $99.7 Million
Continued Strong Growth and Increasing Momentum for Invisalign Clear Aligners and iTero Systems and Services Across Products and Customer Channels Worldwide, Reflects the Strength of Align’s Doctor-Directed Model and the Align Digital Platform $99.7 million award includes the $54.2 million paid to Align to date for the capital account SDC required to pay $45.5 million and additional ...
-
Align Technology announces winner of 2020 Invisalign Ortho Summit Case Shoot-Out
Align Technology, Inc. (NASDAQ: ALGN) today announced the winner of the 2020 Invisalign Ortho Summit Case Shoot-out, one of the Company’s live case presentations during the virtual Summit. Dr. Keith Sellers of Charlotte, North Carolina received the greatest number of attendee votes for his Class II/Class III Invisalign case presentation. The Invisalign Ortho Summit Case Shoot-out program ...
-
Asensus Surgical Announces FDA Clearance in General Surgery
Asensus Surgical, Inc. (formerly TransEnterix, Inc.) (NYSE American: TRXC) , a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, today announced the Company has received an additional FDA clearance for the Senhance Surgical System which allows for indication expansion in general surgery in the United ...
-
Novaerus Defend 1050 cleared by FDA as 510(k) Class II Medical Device
Defend 1050 uses patented NanoStrike® technology to damage and inactivate airborne micro-organisms. Dublin, Ireland and Stamford, CT - Novaerus, a WellAir company that delivers clean air solutions to help prevent the spread of infectious outbreaks, announced today that the U.S. Food and Drug Administration (FDA) cleared the Novaerus Defend 1050 (NV 1050) as a 510(k) Class II Medical Device ...
By WellAir
-
Carmat outlines commercial and development plan for its total artificial heart
Addressable market in the bridge-to-transplant indication of more than 2,000 patients a year in Europe Company prepares for commercial launch in Q2 2021, with initial focus on Germany and France Robust clinical plan to support adoption and sales development Virtual conference with Stéphane Piat today at 5 pm CET CARMAT (FR0010907956, ALCAR), the designer and developer of the ...
By Carmat
-
Atmo exhibits at Australian Gastroenterology Week
Atmo Biosciences exhibited at Australian Gastroenterology Week Conference in Adelaide thanks to the generous support of C.R. Kennedy. CEO Mal Hebblewhite reported plenty of interest from gastroenterologists regarding the two clinical trials Atmo recently commenced with Professor Peter Gibson at Monash University. There was also lots of discussion about using the Atmo Gas Capsule as a research ...
-
Disposal of used COVID-19 masks and gloves
Coronavirus pandemic forces us to social distancing and to wear surgical masks and disposable gloves. For this reason millions of surgical masks and gloves are used every day and disposed of after use, not only in hospitals – the front line against the virus – but also by all of us. Therefore disposal of used COVID-19 masks and gloves is a major issue because this waste may be ...
-
Espoo Health Services chose Genano to protect patients and staff from viruses in the air
Espoo Health Services was well prepared for the expansion of the corona epidemic and reorganized its operations. One of the tasks was to change the Samaria health station in the center of Espoo, Finland, into an infection center focusing on the treatment of respiratory infections. In the next phase, another health station was prepared for similar use in case the first infection center's ...
-
ExThera’s Affinity Blood Filter Is Used to Treat COVID-19 Patients
Treatment of COVID-19 with ExThera’s Seraph®100 Microbind® Affinity Blood Filter (Seraph 100) has begun in hospitals in Germany and Italy. Seraph 100 treatments of COVID-19 are also expected to begin soon in France and the USA. Seraph 100 is the only ‘hemoperfusion device’ approved for the reduction of pathogens in blood. In recent EU clinical cases improved lung ...
-
Infection transmission prevention and control of Coronavirus (COVID-19) made possible through Genano Air Decontamination Units
Infection control procedures including work practices, protocols and controls, environmental hygiene, air filtration and appropriate use of Personal Protective Equipment (PPE) are all necessary to prevent infections from spreading during healthcare service delivery. But in the case of the recent Coronavirus (COVID-19) outbreak early detection and isolation of potentially infectious patients is ...
-
Efforts to Sequence the Coronavirus Continue as New Gene Sequencer is Launched in Asia
The Wuhan Coronavirus continues to spread throughout China and other parts of the globe. In efforts to understand more about the virus, it's different strains and how it spreads, scientists are turning to genetic sequencing. By studying the different strains and genetic mutations found in individuals that are infected by the Coronavirus, it is hoped that a containment solution could potentially ...
-
AdjuCor enters BMBF supported research collaboration for developing 3D printable biomimetic polymers that mimic properties of the pericardium.
MUNICH, Germany – February 4th, 2020: In the future, novel polymers should make it possible to individually manufacture artificial elastic tissue replacements for pericardium, heart valves or blood vessels. In the PolyKARD project, biomimetic polymers are being developed that can imitate the mechanical properties of pericardial tissue. Using 3D printing and electrospinning, these ...
By AdjuCor GmbH
-
Here`s What You Can`t Miss at CES 2020
CES® 2020 is the world’s largest and most influential tech event, where the entire technology ecosystem gathers to conduct business, launch products, build brands and partner to solve some of the world’s most challenging issues. More than 4,500 exhibitors will launch nearly 20,000 new transformative tech products to more than 170,000 attendees, encompassing 5G connectivity, ...
-
Some Health Care Professionals in Puerto Rico at Risk of Exposure to Waste Anesthetic Gases
Waste anesthetic gases (WAGs) are small amounts of volatile anesthetic gases that leak from a patient’s anesthetic breathing circuit into the air of operating rooms during the delivery of anesthesia. These gases may also be exhaled by patients recovering from anesthesia. Waste anesthetic gases include both nitrous oxide and halogenated anesthetics. The Occupational Safety and Health ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you